Abstract
This study investigated the inhibitory action of human calcitonin-gene-related peptide (CGRP) on neurotransmission in rat isolated vas deferens. The electrically stimulated contractile responses, which were mediated predominantly by activation of postganglionic noradrenergic nerve fibers, were concentration-dependently inhibited by human CGRP (0.1–100 nM, IC 50=2.15±0.21 nM, n=17). Human CGRP at concentrations greater than 3 nM reduced the contractile responses to exogenous noradrenaline and ATP. The inhibitory effect of human CGRP on the electrically stimulated or agonist-induced contractions was antagonized by human CGRP-(8–37), the CGRP receptor antagonist. Glibenclamide (3–10 μM) decreased the effect of human CGRP at a concentration greater than 1 nM whilst glibenclamide did not affect the inhibitory effect of human CGRP on the agonist-induced contractions. These results indicate that human CGRP at low concentrations exerts its inhibitory action mainly by acting on CGRP receptors at the sympathetic nerve terminals supplying rat vas deferens and the activation of ATP-sensitive K + channels is at least in part involved in the action of human CGRP on neurotransmission.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
